Filana Therapeutics, Inc. Operating Expenses
Filana Therapeutics, Inc. (FLNA) reported Operating Expenses of $11.17 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-07
- Filana Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $11.17M, a 54.58% decline year-over-year.
- Filana Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $13.55M, a 54.04% decline year-over-year.
- Filana Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $11.86M, a 61.27% decline year-over-year.
- Filana Therapeutics, Inc. operating expenses for the quarter ending 2025-06-30 was $45.39M, a 26.07% decline year-over-year.
- Filana Therapeutics, Inc. operating expenses for fiscal 2025 was $95.39M, a 32.56% decline from fiscal 2024.
- Filana Therapeutics, Inc. operating expenses for fiscal 2024 was $141.45M, a 33.49% increase from fiscal 2023.
- Filana Therapeutics, Inc. operating expenses for fiscal 2023 was $105.96M, a 32.41% increase from fiscal 2022.
- Filana Therapeutics, Inc. operating expenses for fiscal 2022 was $80.02M, a 143.46% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $11.17M 10-Q · filed 2026-05-07 | $24.72M derived: sum of 2 quarters · filed 2026-05-07 | $36.58M derived: sum of 3 quarters · filed 2026-05-07 | $81.97M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $25.41M derived: sum of 2 quarters · filed 2026-03-12 | $70.80M derived: sum of 3 quarters · filed 2026-03-12 | $95.39M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $11.86M 10-Q · filed 2025-11-12 | $57.25M derived: sum of 2 quarters · filed 2025-11-12 | $81.84M 10-Q · filed 2025-11-12 | $111.33M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-06-30 | $45.39M 10-Q · filed 2025-08-14 | $69.98M 10-Q · filed 2025-08-14 | $99.47M derived: sum of 3 quarters · filed 2026-05-07 | $130.09M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-03-31 | $24.59M 10-Q · filed 2026-05-07 | $54.07M derived: sum of 2 quarters · filed 2026-05-07 | $84.70M derived: sum of 3 quarters · filed 2026-05-07 | $146.10M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $29.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $60.11M derived: sum of 2 quarters · filed 2026-03-12 | $121.51M derived: sum of 3 quarters · filed 2026-03-12 | $141.45M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $30.62M 10-Q · filed 2025-11-12 | $92.03M derived: sum of 2 quarters · filed 2025-11-12 | $111.96M 10-Q · filed 2025-11-12 | $134.75M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-06-30 | $61.40M 10-Q · filed 2025-08-14 | $81.34M 10-Q · filed 2025-08-14 | $104.13M derived: sum of 3 quarters · filed 2026-03-12 | $132.00M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-03-31 | $19.93M 10-Q · filed 2025-05-08 | $42.72M derived: sum of 2 quarters · filed 2026-03-12 | $70.60M derived: sum of 3 quarters · filed 2026-03-12 | $99.38M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2023-12-31 | $22.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $50.67M derived: sum of 2 quarters · filed 2026-03-12 | $79.44M derived: sum of 3 quarters · filed 2026-03-12 | $105.96M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $27.88M 10-Q · filed 2024-11-07 | $56.66M derived: sum of 2 quarters · filed 2024-11-07 | $83.17M 10-Q · filed 2024-11-07 | $104.11M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $28.78M 10-Q · filed 2024-08-08 | $55.29M 10-Q · filed 2024-08-08 | $76.23M derived: sum of 3 quarters · filed 2025-03-03 | $97.57M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $26.51M 10-Q · filed 2024-05-10 | $47.45M derived: sum of 2 quarters · filed 2025-03-03 | $68.79M derived: sum of 3 quarters · filed 2025-03-03 | $88.71M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $20.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $42.28M derived: sum of 2 quarters · filed 2025-03-03 | $62.20M derived: sum of 3 quarters · filed 2025-03-03 | $80.02M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $21.34M 10-Q · filed 2023-11-07 | $41.26M derived: sum of 2 quarters · filed 2023-11-07 | $59.08M 10-Q · filed 2023-11-07 | $73.53M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $19.92M 10-Q · filed 2023-08-03 | $37.74M 10-Q · filed 2023-08-03 | $52.18M derived: sum of 3 quarters · filed 2024-02-28 | $61.94M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $17.82M 10-Q · filed 2023-05-01 | $32.27M derived: sum of 2 quarters · filed 2024-02-28 | $42.02M derived: sum of 3 quarters · filed 2024-02-28 | $47.16M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $14.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $24.20M derived: sum of 2 quarters · filed 2024-02-28 | $29.34M derived: sum of 3 quarters · filed 2024-02-28 | $32.87M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $9.75M 10-Q · filed 2022-11-07 | $14.89M derived: sum of 2 quarters · filed 2022-11-07 | $18.42M 10-Q · filed 2022-11-07 | $21.05M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $5.14M 10-Q · filed 2022-08-04 | $8.67M 10-Q · filed 2022-08-04 | $11.29M derived: sum of 3 quarters · filed 2023-02-28 | $12.73M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $3.53M 10-Q · filed 2022-05-05 | $6.16M derived: sum of 2 quarters · filed 2023-02-28 | $7.59M derived: sum of 3 quarters · filed 2023-02-28 | $8.76M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.06M derived: sum of 2 quarters · filed 2023-02-28 | $5.22M derived: sum of 3 quarters · filed 2023-02-28 | $6.45M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $1.44M 10-Q · filed 2021-11-15 | $2.60M derived: sum of 2 quarters · filed 2021-11-15 | $3.82M 10-Q · filed 2021-11-15 | $5.40M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.16M 10-Q · filed 2021-08-04 | $2.38M 10-Q · filed 2021-08-04 | $3.96M derived: sum of 3 quarters · filed 2021-08-04 | $4.74M derived: sum of 4 quarters · filed 2021-08-04 | |
| 2020-03-31 | $1.22M 10-Q · filed 2021-04-29 | $2.80M derived: sum of 2 quarters · filed 2021-04-29 | $3.58M derived: sum of 3 quarters · filed 2021-04-29 | $4.73M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $2.35M derived: sum of 2 quarters · filed 2021-03-23 | $3.51M derived: sum of 3 quarters · filed 2021-03-23 | $4.96M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $779.00K 10-Q · filed 2020-11-09 | $1.93M derived: sum of 2 quarters · filed 2020-11-09 | $3.38M 10-Q · filed 2020-11-09 | $4.13M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $1.15M 10-Q · filed 2020-08-12 | $2.60M 10-Q · filed 2020-08-12 | $3.35M derived: sum of 3 quarters · filed 2020-08-12 | $4.64M derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-06 | $2.20M derived: sum of 2 quarters · filed 2020-05-06 | $3.48M derived: sum of 3 quarters · filed 2020-05-06 | $5.95M derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $2.03M derived: sum of 2 quarters · filed 2020-03-26 | $4.50M derived: sum of 3 quarters · filed 2020-03-26 | $6.66M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.28M 10-Q · filed 2019-10-29 | $3.75M derived: sum of 2 quarters · filed 2019-10-29 | $5.91M 10-Q · filed 2019-10-29 | $8.34M derived: sum of 4 quarters · filed 2019-10-29 | |
| 2018-06-30 | $2.46M 10-Q · filed 2018-07-26 | $4.63M 10-Q · filed 2019-08-12 | $7.05M derived: sum of 3 quarters · filed 2019-05-02 | $9.65M derived: sum of 4 quarters · filed 2019-05-02 | |
| 2018-03-31 | $2.17M 10-Q · filed 2019-05-02 | $4.59M derived: sum of 2 quarters · filed 2019-05-02 | $7.19M derived: sum of 3 quarters · filed 2019-05-02 | $11.35M derived: sum of 4 quarters · filed 2019-05-02 | |
| 2017-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $5.02M derived: sum of 2 quarters · filed 2019-03-29 | $9.19M derived: sum of 3 quarters · filed 2019-03-29 | $11.95M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $2.60M 10-Q · filed 2018-10-30 | $6.76M derived: sum of 2 quarters · filed 2018-10-30 | $9.53M 10-Q · filed 2018-10-30 | $12.07M derived: sum of 4 quarters · filed 2018-10-30 | |
| 2017-06-30 | $4.17M 10-Q · filed 2018-07-26 | $6.93M 10-Q · filed 2018-07-26 | $9.47M derived: sum of 3 quarters · filed 2018-07-26 | $13.01M derived: sum of 4 quarters · filed 2018-07-26 | |
| 2017-03-31 | $2.76M 10-Q · filed 2018-05-09 | $5.31M derived: sum of 2 quarters · filed 2018-05-09 | $8.85M derived: sum of 3 quarters · filed 2018-05-09 | $11.89M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-06 | $6.08M derived: sum of 2 quarters · filed 2018-02-06 | $9.13M derived: sum of 3 quarters · filed 2018-02-06 | $14.96M 10-K · filed 2018-02-06 | |
| 2016-09-30 | $3.54M 10-Q · filed 2017-11-01 | $6.58M derived: sum of 2 quarters · filed 2017-11-01 | $12.41M 10-Q · filed 2017-11-01 | $16.95M derived: sum of 4 quarters · filed 2017-11-01 | |
| 2016-06-30 | $3.04M 10-Q · filed 2017-08-09 | $8.87M 10-Q · filed 2017-08-09 | $13.41M derived: sum of 3 quarters · filed 2017-08-09 | $17.09M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-03-31 | $5.83M 10-Q · filed 2017-04-26 | $10.36M derived: sum of 2 quarters · filed 2017-04-26 | $14.05M derived: sum of 3 quarters · filed 2017-04-26 | $17.44M derived: sum of 4 quarters · filed 2017-04-26 | |
| 2015-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $8.22M derived: sum of 2 quarters · filed 2017-03-07 | $11.61M derived: sum of 3 quarters · filed 2017-03-07 | $14.20M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $3.69M 10-Q · filed 2016-10-26 | $7.07M derived: sum of 2 quarters · filed 2016-10-26 | $9.67M 10-Q · filed 2016-10-26 | $11.84M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-06-30 | $3.39M 10-Q · filed 2016-07-19 | $5.98M 10-Q · filed 2016-07-19 | $8.15M derived: sum of 3 quarters · filed 2017-03-07 | $11.69M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-03-31 | $2.60M 10-Q · filed 2016-05-05 | $4.76M derived: sum of 2 quarters · filed 2017-03-07 | $8.31M derived: sum of 3 quarters · filed 2017-03-07 | $11.56M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2014-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $5.71M derived: sum of 2 quarters · filed 2017-03-07 | $8.97M derived: sum of 3 quarters · filed 2017-03-07 | $12.43M 10-K · filed 2017-03-07 | |
| 2014-09-30 | $3.54M 10-Q · filed 2015-11-09 | $6.80M derived: sum of 2 quarters · filed 2015-11-09 | $10.27M 10-Q · filed 2015-11-09 | $12.61M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2014-06-30 | $3.26M 10-Q · filed 2015-07-23 | $6.72M 10-Q · filed 2015-07-23 | $9.06M derived: sum of 3 quarters · filed 2016-03-03 | $11.80M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2014-03-31 | $3.46M 10-Q · filed 2015-05-08 | $5.80M derived: sum of 2 quarters · filed 2016-03-03 | $8.54M derived: sum of 3 quarters · filed 2016-03-03 | $10.82M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2013-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $5.08M derived: sum of 2 quarters · filed 2016-03-03 | $7.35M derived: sum of 3 quarters · filed 2016-03-03 | $9.75M 10-K · filed 2016-03-03 | |
| 2013-09-30 | $2.73M 10-Q · filed 2014-11-05 | $5.01M derived: sum of 2 quarters · filed 2014-11-05 | $7.41M 10-Q · filed 2014-11-05 | $11.72M derived: sum of 4 quarters · filed 2015-02-18 | |
| 2013-06-30 | $2.28M 10-Q · filed 2014-08-06 | $4.68M 10-Q · filed 2014-08-06 | $8.99M derived: sum of 3 quarters · filed 2015-02-18 | $13.37M derived: sum of 4 quarters · filed 2015-02-18 | |
| 2013-03-31 | $2.40M 10-Q · filed 2014-05-07 | $6.71M derived: sum of 2 quarters · filed 2015-02-18 | $11.09M derived: sum of 3 quarters · filed 2015-02-18 | $14.07M derived: sum of 4 quarters · filed 2015-02-18 | |
| 2012-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $8.69M derived: sum of 2 quarters · filed 2015-02-18 | $11.66M derived: sum of 3 quarters · filed 2015-02-18 | $14.79M 10-K · filed 2015-02-18 | |
| 2012-09-30 | $4.38M 10-Q · filed 2013-11-01 | $7.36M derived: sum of 2 quarters · filed 2013-11-01 | $10.48M 10-Q · filed 2013-11-01 | $13.81M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2012-06-30 | $2.98M 10-Q · filed 2013-08-01 | $3.00M 10-Q · filed 2012-08-02 | $6.10M 10-Q · filed 2013-08-01 | $9.43M derived: sum of 3 quarters · filed 2014-02-05 | $13.20M derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-03-31 | $3.12M 10-Q · filed 2013-04-24 | $6.45M derived: sum of 2 quarters · filed 2014-02-05 | $10.22M derived: sum of 3 quarters · filed 2014-02-05 | $14.40M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2011-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-05 | $7.10M derived: sum of 2 quarters · filed 2014-02-05 | $11.28M derived: sum of 3 quarters · filed 2014-02-05 | $15.00M 10-K · filed 2014-02-05 | |
| 2011-09-30 | $3.77M 10-Q · filed 2012-11-09 | $7.95M derived: sum of 2 quarters · filed 2012-11-09 | $11.67M 10-Q · filed 2012-11-09 | $29.19M derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-06-30 | $4.18M 10-Q · filed 2012-08-02 | $7.89M 10-Q · filed 2012-08-02 | $25.41M derived: sum of 3 quarters · filed 2013-02-08 | $29.88M derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-03-31 | $3.71M 10-Q · filed 2012-05-08 | $21.23M derived: sum of 2 quarters · filed 2013-02-08 | $25.70M derived: sum of 3 quarters · filed 2013-02-08 | $29.61M derived: sum of 4 quarters · filed 2013-02-08 | |
| 2010-12-31 | $17.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $21.99M derived: sum of 2 quarters · filed 2013-02-08 | $25.90M derived: sum of 3 quarters · filed 2013-02-08 | $30.51M 10-K · filed 2013-02-08 | |
| 2010-09-30 | $4.47M 10-Q · filed 2011-11-03 | $8.38M derived: sum of 2 quarters · filed 2011-11-03 | $12.99M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $3.91M 10-Q · filed 2011-08-04 | $8.52M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $27.32M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |